{"name":"Global United Pharmaceutical Corporation","slug":"global-united-pharmaceutical-corporation","ticker":"","exchange":"","domain":"","description":"Global United Pharmaceutical Corporation is a specialty pharmaceutical company focused on developing and commercializing niche therapeutic solutions. The company has a limited public profile but is actively engaged in Phase 2 clinical trials for its lead product, an antipyrine-benzocaine otic solution.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Antipyrine-benzocaine otic solution","genericName":"Antipyrine-benzocaine otic solution","slug":"antipyrine-benzocaine-otic-solution","indication":"Ear pain relief","status":"phase_2"}]}],"pipeline":[{"name":"Antipyrine-benzocaine otic solution","genericName":"Antipyrine-benzocaine otic solution","slug":"antipyrine-benzocaine-otic-solution","phase":"phase_2","mechanism":"Antipyrine-benzocaine otic solution works by providing local anesthetic and analgesic effects to the ear.","indications":["Ear pain relief","Otitis externa treatment"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxQbkk4RVM2cUo5VGtyaWdnc3RMSG53bUlMbEtNb2dyZHcwWEd1M3BJaGIzclhvTzFhLUJXQlJlRXpLLS15bWN5MkRWMXE4YzNxX00tZEk5ZGp2ZWtkdUduUHV0eE9wY0p0Sm5DYzZNTHd4QjdWdS1lTU5UMVo3U0tKUEl4eE5DcmhkbXhXbGRMbmxXOFN0aVJXUl9wVlRwdTJfTnMzU1hoT0VBTG4xeFA3WW1UOFJNTEJ1VEpJMmFPNlN6SDBFWXJ0bGQwN0lRaDYxX2tQZl9XOXJ6ZGp4U3Vpby1mUDhmMzFrbVMwU01ycnlWZEh3NkVMSTN6SkEyc2lzRnpKeUVFSDRRc3N1WjV1WWxKOERXSkI1cmxjVmh0VndTWjRuTmNqM095cW1Jc2pVcUFRRkU4TGFjOXN3UlBianctbUxfb1NhMWF5Z1BR?oc=5","date":"2026-03-26","type":"pipeline","source":"Barchart.com","summary":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - B","headline":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxQWTJVTGh0ejN2YjM1TlN0dzlINUI2X0dubnVSWHdzTGxaZFBRM3RqNm14LWdMWERyamxIbW1YTHZLRWhpbDhDR3dFNHIwSWxMWGZOQXBweEpPdG9qakYwNUoySzZZN0lQQlV2a1FDX0Z0ZmxDYlREY0tmSVpYYkR6YjY4OWlseUFTWmF3VG1fMElGeXNTczZsTEFFdFpOTy1JN3ZJMnd5NGFTNXpaeXRINnNkWVBTVW1zbUlwZGNROUZnR0xvcXpLcFh1dXdmMEFMUGJYU2dMNV9Zdm9VcktZMUU4WUQzZmxrcEdqVXRQT1RtbWhlS1NZYTk0WmVqWUdZakhvZGIwaVdMVU84MDAyNkVZOFhlNkRFODR5T2ZzTzQzOWpPMjF0cktlcDVZNl9Nc0hkbWc5ZldWZm1iSlVNaWx3aURiWF9lUnc?oc=5","date":"2026-03-26","type":"pipeline","source":"Barchart.com","summary":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - B","headline":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPcVdMZWZpTkVzTDBhV0lneFZGTGVqdy10RFk1bVVQS2NURnVuNjhWYUxxYjBUN3ZFWXNYTzF5enk4c1lHRTlWQWtsdmpVdHc2LW9YVkwyWnllZnkyREQzSldDMU1hYnR2bC0yLVFScDQ5Q0p4dElyZUlUZE5pdkNuY1pLSk1VQmJOaUJTUXBRQnppNWJwVGJlVUFnWG1wTzdpUmVJOTFqV3U2ZWo4aWx3RkVpNGV2TVU?oc=5","date":"2026-03-24","type":"pipeline","source":"UNEP - UN Environment Programme","summary":"Pharmaceuticals in the Environment - UNEP - UN Environment Programme","headline":"Pharmaceuticals in the Environment - UNEP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNMnB4VkQ3a21JNnJ3eXhORndac2lvVmNXQ0otdXFUdFpwZzF5VXFMbHpER1htR1AydlJmcWozalJWcjdIbHhWSkp0aW1hSUl5Z0tFZ2sweldWYzVvR01jVy1FZlcwY01FZjhsWWd3S3lQSkdRYVc2ME54TDNNc0wxVDlLR3NORHdCb0ZTMk03Yl9PcmRx?oc=5","date":"2026-03-13","type":"earnings","source":"Statista","summary":"Major pharma companies by U.S. revenue 2025 - Statista","headline":"Major pharma companies by U.S. revenue 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNQ0ItclBMRGNwTzg0MHlVSXdMbWFSdFFhOGhfVUVLbEJja0pycjRkUTVGX19zeElUQ1g3YlpkSU1aemlqVGluNlA4S3l6ZGxIMk9mTWNrSURZTGRUdTVnWnVsUEtmMlJxclJuZzJ3U092WmVtWnB5RjJMMlpLMENYbHBJQUlaOEFPV2k1cS0xSndJZFVXWmxrbU1wOFljUFVYSlhRRVhSOFBINk1Z?oc=5","date":"2026-03-11","type":"earnings","source":"Statista","summary":"Major U.S. biotech & pharma companies by revenue 2026 - Statista","headline":"Major U.S. biotech & pharma companies by revenue 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxPZUNKZ0d6d1JkOUJDTlF2ZEJuUGEwQXNYRFpRdmtZOGJwUE13cE9RRHhnZDBiQTQyYjBYVkJZN0R5UXRWaVVxRGJWajhWa2NGQzFDVUlBZEF1bHA5ZHVfTWNoNHB3eXR2ckQ1M2dDcnNWY3Rqd1hhUmctZ1QwTk1qeFMzRWJhVFlyV3pQZkx5THpuU2hvNEJuQ2dkb1gzYXV0X0NtUkJmdnA3QllCWjZLV0EzeFZObFRQaUVDTE1BaHNDeGNnOXltYXhJalMzREFXZGtOYUZEWTE1WklmTU5NbC0tS09RUQ?oc=5","date":"2026-02-24","type":"pipeline","source":"PR Newswire","summary":"Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada - PR Newswire","headline":"Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPY3lZYS11TkYxQ1RUbE9OaXJzT1NaYXR0OWtBdTFlbW94Ujd1QjRNamlfTWNzeld6cWY5U3lid1kzaTJIOUNYNlotcl9TZzdRcVhjRFNvSTRrYTN2OVkxdU5rVVZ1ajdUV0drdkQ4SkJ6Mi0wbVRleWQ0NzJsejc1LVdReTNjM0xVbWxyZXhsY25tRlV3S0hOZ1lyazFrREhNSXBPWTNWWmxHRkwwa1lHckt6TFJhb3NCWkh0NGNPSWNSVkRrUUhfUFRnZUNLeTlMd2VHZWg2Ul9uaUZ6SG5R?oc=5","date":"2026-02-24","type":"trial","source":"Reuters","summary":"Novo Nordisk, United Laboratories 'triple G' drug trial shows 19.7% weight loss - Reuters","headline":"Novo Nordisk, United Laboratories 'triple G' drug trial shows 19.7% weight loss","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNcWFsSjRuNDgydlhhSjhMRHNpWkZDN19LTkN6Q3ZoWHdudkF6OXFVdzY5eHFsQUFuWDVhcEplaDY1OW15MndLUnJfUy1zeERQcHNUNmhEQjFKZGRPRjk3eUFTQWhaclhYMnl4M25WN0ZHQnl0MU1GbjlERVd6Qkk4VHYwbHpiOEs4amRfNDh2R29rU0t2VENlejhKV01ScHFSNTlhNklXdw?oc=5","date":"2026-02-19","type":"pipeline","source":"Statista","summary":"Top national pharma markets by market share - Statista","headline":"Top national pharma markets by market share","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFA3N0dnNlQteGtOdm9lamh3VXpOOUxfRnZSR05NMk9oTzZMTVA5ZXl1VjktSElsVURScXBOMnpObEg3RHk3WnFSNlJHZExGc2xMZnhEbmZGWENTZlFWQ1pyczlRQTB6dUh5Y3VveEJB0gFyQVVfeXFMTi1YbFM1NWF2elVDQVJCc3Yxc1ktWHlFVlItNUs0NkpwM1Q5OFFWWTcwaU5UYlRWME8xMjIxaHcydzI0OUlTOEM4X3BVY1lkRXMtQjVZckRVaXRPdFBQMUFMQ1FEUmp4M3pMSXFZZldkZENB?oc=5","date":"2026-02-10","type":"pipeline","source":"koreabiomed.com","summary":"Korea United Pharm ramps up UN-focused public procurement biz - koreabiomed.com","headline":"Korea United Pharm ramps up UN-focused public procurement biz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOUXpkX0syamF1amVTajdnMHJDdWV0T0gxLUR5aTBVNVRraW1DSVBLVHFNRGhnSkl6N1F3eGdXNGYxWjhPTzZEV0lwUDRxY1Q4bkdpTUZIN1ZJNGpSYm8yV1hCUVNCSzVMU1ctVXhVQVlpOHpBMlF2N3pJVUJaUERXMFpweTFwcHBZUDdHUWlIV0N0RGR3cEI5UkdtaDk4SG1aT2Vka2ZYbXZwa3JHV3Aya05QMEg5YjZKTENtdGFvMA?oc=5","date":"2026-01-20","type":"pipeline","source":"Hinrich Foundation","summary":"How US tariffs impact global pharmaceutical trade and patients | White paper - Hinrich Foundation","headline":"How US tariffs impact global pharmaceutical trade and patients | White paper","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNaDIwR3ZzRG0xMjNBWDZPcGdxN0RzQWVQbTF3clN4NVpWWXFuZ0ZDdHBzV2hfdHBZNkwyazhscWw1Z0JyYWpkRGhKei1nSTVHcHpMbjNGeGJmNF81cTVLM2dOS0pZREtFc0tGSGxBZENOckl3a05aYl9tLTVWUjFEOWc0al92akFHN0NsQg?oc=5","date":"2025-11-24","type":"pipeline","source":"Think Global Health","summary":"Tracking Pharma's Progress on U.S. Onshoring Efforts to Avoid Tariffs - Think Global Health","headline":"Tracking Pharma's Progress on U.S. Onshoring Efforts to Avoid Tariffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNOW1STDVPZVRTWkRlYXlPbVdLb3o5R1hTNUdfUTdyb3ZXazVTSU1raVRGZWZHZnpQUVR4SndzVHhHcmtpZGxoUGVESThfTWM2Zlp2NjF0OGVEU0ZrVlBQTDlwY1BEM3ZjYVdLb2FrSTZlUVFjY1RmOXBwS05NTEU1SGZHc2I3dW1GOUwtakJHWC1MbVNJMXJkckxLVllTN2VmeVFxSWZwY0swTEU3dGh2MjZWNUhxZnVJX1o1dDZvTV85Rk1FR3FZUFA1MTB1ZzNIMl9iSjhoWndseFAxSHVienc0MA?oc=5","date":"2025-10-29","type":"pipeline","source":"Central New Jersey News","summary":"Global pharmaceutical firm chooses Bridgewater for new corporate offices - Central New Jersey News","headline":"Global pharmaceutical firm chooses Bridgewater for new corporate offices","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}